Comment: G-BA Decision on Cannabis Prescription – A Step Forward or Just a Placebo for Doctors?
Berlin, October 16, 2024 – The introduction of the new G-BA decision, which allows doctors with certain specialist, focus, or additional qualifications to prescribe medical cannabis without prior approval from health insurance companies, is being celebrated as progress. But beneath the surface, skepticism lingers. Rather than truly easing the prescription of cannabinoids, this decision could […]